Abstract
Many prospective cohort studies have investigated the association between the consumption of alcohol and CKD risk and have revealed inconsistent results. In the present study, we aimed to perform a meta-analysis of these studies to assess this association.We searched the PubMed and Embase databases up to 2020 and reviewed the reference lists of relevant articles to identify appropriate studies. We calculated the pooled relative risks with 95% CIs using random effects models, and then performed subgroup and meta-regression analyses. Dose–response meta-analyses were performed by sex separately. We identified 25 eligible prospective cohort studies, including 514,148 participants and 35,585 incident CKD cases. Compared with the category of minimal alcohol intake, light (RR = 0.90, I2 = 49%), moderate (RR = 0.86, I2 = 40%), and heavy (RR = 0.85, I2 = 51%) alcohol intake were associated with a lower risk of CKD. Subgroup meta-analysis by sex indicated that light (RR = 0.92, I2 = 0%), moderate (RR = 0.83, I2 = 39%) and heavy (RR = 0.76, I2 = 40%), alcohol consumption were inversely associated with CKD risk in male. Dose–response meta-analyses detected a nonlinear inverse association between alcohol consumption and the risk of CKD in all participants and linear inverse association in female participants. This meta-analysis shows that light (<12 g/day), moderate (12–24 g/day), and heavy (>24 g/day) alcohol consumption are protective against chronic kidney disease in adult participants especially in males.
Similar content being viewed by others
References
Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382:260–72.
Yasmin A, Zaman HH. Chronic kidney disease screening methods and its implication for Malaysia: an in depth review. Glob J Health Sci. 2015;7:96–109.
Foundation NK, Doqi K. K\DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:s1–s266.
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–128.
Jha V. Current status of chronic kidney disease care in southeast Asia. Semin Nephrol. 2009;29:487–96.
Ritz E, Schwenger V. Lifestyle modification and progressive renal failure. Nephrology. 2010;10:387–92.
Dawson DA, Grant BF, Stinson FS, Chou PS. Toward the attainment of low-risk drinking goals: a 10-year progress report. Alcohol Clin Exp Res. 2010;28:1371–8.
Perneger TV, Whelton PK, Puddey IB, Klag MJ. Risk of end-stage renal disease associated with alcohol consumption. Am J Epidemiol. 1999;150:1275–81.
Fored CM, Ejerblad E, Fryzek JP, Lambe M, Lindblad P, Nyrén O, et al. Socio-economic status and chronic renal failure: a population-based case-control study in Sweden. Nephrol Dial Transplant. 2003;18:82–8.
Cheungpasitporn W, Thongprayoon C, Kittanamongkolchai W, Brabec BA, O’Corragain OA, Edmonds PJ, et al. High alcohol consumption and the risk of renal damage: a systematic review and meta-analysis. QJM. 2015;108:539–48.
Knobloch K, Yoon U, Vogt PM. Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias. J Cranio-Maxillofac Surg. 2011;39:91–92.
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–5.
Zhang J, Yu KF. What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280:1690–1.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.
Higgins JP, Thompson SG. Controlling the risk of spurious findings from meta-regression. Stat Med. 2004;23:1663–82.
Xu C, Doi SAR. The robust error meta-regression method for dose-response meta-analysis. Int J Evid Based Health. 2018;16:138–44.
Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med. 1989;8:551–61.
Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1998;316:469–71.
Menon V, Katz R, Mukamal K, Kestenbaum B, Boer IHD, Siscovick DS, et al. Alcohol consumption and kidney function decline in the elderly: alcohol and kidney disease. Nephrol Dial Transplant. 2010;25:3301–7.
Knight EL, Stampfer MJ, Rimm EB, Hankinson SE, Curhan GC. Moderate alcohol intake and renal function decline in women: a prospective study. Nephrol Dial Transplant. 2003;18:1549–54.
Foster MC, Hwang SJ, Massaro JM, Jacques PF, Fox CS, Chu AY. Lifestyle factors and indices of kidney function in the Framingham Heart Study. Am J Nephrol. 2015;41:267–74.
Shankar A, Klein R, Klein BEK. The association among smoking, heavy drinking, and chronic kidney disease. Am J Epidemiol. 2006;164:263–71.
Stengel B, Tarvercarr ME, Powe NR, Eberhardt MS, Brancati FL. Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology. 2003;14:479–87.
Hu EA, Lazo M, Rosenberg SD, Grams ME, Steffen LM, Coresh J, et al. Alcohol consumption and incident kidney disease: results from the atherosclerosis risk in communities study. J Ren Nutr. 2020;30:22–30.
Schaeffner ES, Kurth T, de Jong PE, Glynn RJ, Buring JE, Gaziano JM. Alcohol consumption and the risk of renal dysfunction in apparently healthy men. Arch Intern Med. 2005;165:1048–53.
Koning SH, Gansevoort RT, Mukamal KJ, Rimm EB, Bakker SJL, Joosten MM. Alcohol consumption is inversely associated with the risk of developing chronic kidney disease. Kidney Int. 2015;87:1009–16.
Buja A, Scafato E, Baggio B, Sergi G, Maggi S, Rausa G, et al. Renal impairment and moderate alcohol consumption in the elderly. Results from the Italian Longitudinal Study on Aging (ILSA). Public Health Nutr. 2011;14:1907–18.
Reynolds K, Gu D, Chen J, Tang X, Yau CL, Yu L, et al. Alcohol consumption and the risk of end-stage renal disease among Chinese men. Kidney Int. 2008;73:870–6.
Ryoma M, Takuro M, Shotaro K, Akira K, Hiroaki T, Natsumi M, et al. The association between unhealthy lifestyle behaviors and the prevalence of chronic kidney disease (CKD) in middle-aged and older men. J Epidemiol. 2016;26:378–85.
Kanda E, Muneyuki T, Suwa K, Nakajima K. Alcohol and exercise affect declining kidney function in healthy males regardless of obesity: a prospective cohort study. PLoS ONE. 2015;10:e0134937.
Wakasugi M, Kazama JJ, Yamamoto S, Kawamura K, Narita I. A combination of healthy lifestyle factors is associated with a decreased incidence of chronic kidney disease: a population-based cohort study. Hypertens Res. 2013;36:328–33.
Nakanishi N, Fukui M, Tanaka M, Toda H, Imai S, Yamazaki M, et al. Low urine pH is a predictor of chronic kidney disease. Kidney Blood Press Res. 2012;35:77–81.
Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007;71:159–66.
Nagai K, Saito C, Watanabe F, Ohkubo R, Sato C, Kawamura T, et al. Annual incidence of persistent proteinuria in the general population from Ibaraki annual urinalysis study. Clin Exp Nephrol. 2013;17:255–60.
Qin X, Wang Y, Li Y, Xie D, Tang G, Wang B, et al. Risk factors for renal function decline in adults with normal kidney function: a 7-year cohort study. J Epidemiol Community Health. 2015;69:782–8.
Okada Y, Uehara S, Shibata M, Koh H, Oue K, Kambe H, et al. Habitual alcohol intake modifies relationship of uric acid to incident chronic kidney disease. Am J Nephrol. 2019;50:55–62.
White SL, Polkinghorne KR, Cass A, Shaw JE, Atkins RC, Chadban SJ. Alcohol consumption and 5-year onset of chronic kidney disease: the AusDiab study. Nephrol Dial Transplant. 2009;24:2464–72.
Dunkler D, Dehghan M, Teo KK, Heinze G, Gao P, Kohl M, et al. Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus. JAMA Intern Med. 2013;173:1682–92.
Mostofsky E, Chahal HS, Mukamal KJ, Rimm EB, Mittleman MA. Alcohol and immediate risk of cardiovascular events: a systematicreview and dose-response meta-analysis. Circulation. 2016;133:979–87.
Larsson SC, Wallin A, Wolk A. Alcohol consumption and risk of heart failure: meta-analysis of 13 prospective studies. Clin Nutr. 2018;37:1247–51.
Gaziano JM, Buring JE, Breslow JL, Goldhaber SZ, Rosner B, Vandenburgh M, et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med. 1993;329:1829–34.
Camargo CA Jr, Williams PT, Vranizan KM, Albers JJ, Wood PD. The effect of moderate alcohol intake on serum apolipoproteins A-I and A-II. A controlled study. JAMA. 1985;253:2854–7.
Muntner P, Coresh J, Smith JC, Eckfeldt J, Klag MJ. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int. 2000;58:293–301.
Mukamal KJ, Jadhav PP, D’Agostino RB. Alcohol consumption and hemostatic factors. Analysis of the Framingham offspring cohort. Acc Curr J Rev. 2002;11:1367–73.
Estruch R, Sacanella E, Badia E, Antúnez E, Nicolás JM, Fernández-Solá J, et al. Different effects of red wine and gin consumption on inflammatory biomarkers of atherosclerosis: a prospective randomized crossover trial. Effects of wine on inflammatory markers. Atherosclerosis. 2004;175:117–23.
Burchfiel CM, Tracy RE, Chyou PH, Strong JP. Cardiovascular risk factors and hyalinization of renal arterioles at autopsy the Honolulu Heart Program. Arterioscler Thromb Vasc Biol. 1997;17:760–8.
Scott RB, Reddy KS, Husain K, Schlorff EC, Rybak LP, Somani SM. Dose response of ethanol on antioxidant defense system of liver, lung, and kidney in rat. Pathophysiology. 2000;7:25–32.
Femia R, Natali A, L’Abbate A, Ferrannini E. Coronary atherosclerosis and alcohol consumption: angiographic and mortality data. Arterioscler Thromb Vasc Biol. 2006;26:1607–12.
Davies MJ, Baer DJ, Judd JT, Brown ED, Campbell WS, Taylor PR. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA. 2002;287:2559–62.
Joosten MM, Beulens JWJ, Kersten S, Hendriks HFJ. Moderate alcohol consumption increases insulin sensitivity and ADIPOQ expression in postmenopausal women: a randomised, crossover trial. Diabetologia. 2008;51:1375–81.
Kwo PY, Ramchandani VA, O’Connor S, Amann D, Carr LG, Sandrasegaran K, et al. Gender differences in alcohol metabolism: relationship to liver volume and effect of adjusting for body mass. Gastroenterology. 1998;115:1552–7.
Silbiger SR, Neugarten J. The role of gender in the progression of renal disease. Adv Ren Replace Ther. 2003;10:3–14.
Dubey RK, Jackson EK. Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms. Am J Physiol Ren Physiol. 2001;280:F365–88.
Emanuele MA, Emanuele N. Alcohol and the male reproductive system. Alcohol Res Health. 2001;25:282–7.
Gavaler JS, Van, Thiel DH. The association between moderate alcoholic beverage consumption and serum estradiol and testosterone levels in normal postmenopausal women: relationship to the literature. Alcohol Clin Exp Res. 1992;16:87–92.
Cook TA, Luczak SE, Shea SH, Ehlers CL, Carr LG, Wall TL. Associations of ALDH2 and ADH1B genotypes with response to alcohol in Asian Americans. J Stud Alcohol. 2005;66:196–204.
Duranceaux NCE, Schuckit MA, Luczak SE, Eng MY, Carr LG, Wall TL. Ethnic differences in level of response to alcohol between Chinese Americans and Korean Americans. J Stud Alcohol Drugs. 2008;69:227–34.
Osier MV, Pakstis AJ, Soodyall H, Comas D, Goldman D, Odunsi A, et al. A global perspective on genetic variation at the ADH genes reveals unusual patterns of linkage disequilibrium and diversity. Am J Hum Genet. 2002;71:84–99.
Goedde HW, Agarwal DP, Fritze G, Meiertackmann D, Singh S, Beckmann G, et al. Distribution of ADH2 and ALDH2 genotypes in different populations. Hum Genet. 1992;88:344–6.
Wall TL, Luczak SE, Susanne HS. Biology, genetics, and environment: underlying factors influencing alcohol metabolism. Alcohol Res. 2016;38:59–68.
Eng MY, Luczak SE, Wall TL. ALDH2, ADH1B, and ADH1C genotypes in Asians: a literature review. Alcohol Res Health. 2007;30:22–27.
Erin D, Qiana B, Hasin DS. Alcohol consumption in demographic subpopulations: an epidemiologic overview. Alcohol Res. 2016;38:7–15.
Rodrigo R, Rivera G, Orellana M, Araya J, Bosco C. Rat kidney antioxidant response to long-term exposure to flavonol rich red wine. Life Sci. 2002;71:2881–95.
Faden VB. Trends in initiation of alcohol use in the United States 1975 to 2003. Alcohol Clin Exp Res. 2006;30:1011–22.
Acknowledgements
The authors would like to thank AJE for English language editing.
Funding
This work was supported by the National Natural Science Foundation of China [grant number 81470498].
Author information
Authors and Affiliations
Contributions
Conceptualization: LYC (second corresponding author) and PG (first corresponding author). Literature search and data collection: HCY and QTY. Data analysis and interpretation: HCY and HB. Drafting of the original manuscript: HCY. Review and editing: HB and HZX.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yuan, H.C., Yu, Q.T., Bai, H. et al. Alcohol intake and the risk of chronic kidney disease: results from a systematic review and dose–response meta-analysis. Eur J Clin Nutr 75, 1555–1567 (2021). https://doi.org/10.1038/s41430-021-00873-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41430-021-00873-x
- Springer Nature Limited